» Articles » PMID: 31820208

Diagnostic Performance of Diffusion-weighted Magnetic Resonance Imaging in Assessing Lymph Node Metastasis of Esophageal Cancer Compared with PET

Overview
Journal Esophagus
Publisher Springer
Date 2019 Dec 11
PMID 31820208
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although diffusion-weighted magnetic resonance imaging (DWI) for detecting lymph node (LN) metastasis is reported to be a successful modality for primary malignant tumors, there are few studies relating to esophageal cancer. This study aimed to clarify the diagnostic performance of DWI for assessing LN metastasis compared with positron emission tomography (PET) in patients with esophageal squamous cell cancer (eSCC).

Methods: Seventy-six patients with histologically proven eSCC who underwent curative esophagectomy without neoadjuvant treatment were reviewed retrospectively. Harvested LNs were divided into 1229 node stations with 94 metastases. Diagnostic abilities and prognostic significance were compared.

Results: In a station-by-station evaluation, the sensitivity was higher in DWI than PET (67% vs. 32%, P < 0.001). DWI showed more than 80% sensitivity for middle- and large-sized cancer nests and large area of cancer nests. The DWI-N0 group had a better 5-year relapse-free survival rate than the DWI-N+ group (78.5% vs. 34.2%, P < 0.001), as did the PET-N0 group. DWI-N status was an independent prognostic factor (hazard ratio [HR], 2.642; P = 0.048), as was PET-N status (HR 2.481; P = 0.033).

Conclusions: DWI, which depends on cancer cell volume followed by elevated intranodal density, is a non-invasive modality and showed higher sensitivity than PET. It has clinical impact in predicting postoperative survival for patients with eSCC alongside its diagnostic ability and has significant performance in clinical practice.

Citing Articles

Value of Computed Tomography Scan for Detecting Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma.

Zeng Y, Liu Y, Li J, Feng B, Lu J Ann Surg Oncol. 2024; 32(3):1635-1650.

PMID: 39586955 DOI: 10.1245/s10434-024-16568-z.


Diffusion-Weighted Magnetic Resonance Imaging for the Diagnosis of Lymph Node Metastasis in Patients with Biliary Tract Cancer.

Murakami T, Shimizu H, Nojima H, Shuto K, Usui A, Kosugi C Cancers (Basel). 2024; 16(18).

PMID: 39335116 PMC: 11430223. DOI: 10.3390/cancers16183143.


Preoperative dual-energy computed tomography and positron-emission tomography evaluation of lymph node metastasis in esophageal squamous cell carcinoma.

Sun X, Niwa T, Kazama T, Okazaki T, Koyanagi K, Kumaki N PLoS One. 2024; 19(9):e0309653.

PMID: 39302928 PMC: 11414887. DOI: 10.1371/journal.pone.0309653.


Radiomics diagnostic performance for predicting lymph node metastasis in esophageal cancer: a systematic review and meta-analysis.

Ma D, Zhou T, Chen J, Chen J BMC Med Imaging. 2024; 24(1):144.

PMID: 38867143 PMC: 11170881. DOI: 10.1186/s12880-024-01278-5.


Radiomics-clinical nomogram for preoperative lymph node metastasis prediction in esophageal carcinoma.

Geng X, Zhang Y, Li Y, Cai Y, Liu J, Geng T Br J Radiol. 2024; 97(1155):652-659.

PMID: 38268475 PMC: 11027331. DOI: 10.1093/bjr/tqae009.


References
1.
Nishimura H, Tanigawa N, Hiramatsu M, Tatsumi Y, Matsuki M, Narabayashi I . Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide. J Am Coll Surg. 2006; 202(4):604-11. DOI: 10.1016/j.jamcollsurg.2005.12.004. View

2.
Pickles M, Gibbs P, Lowry M, Turnbull L . Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging. 2006; 24(7):843-7. DOI: 10.1016/j.mri.2005.11.005. View

3.
van Westreenen H, Westerterp M, Bossuyt P, Pruim J, Sloof G, van Lanschot J . Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol. 2004; 22(18):3805-12. DOI: 10.1200/JCO.2004.01.083. View

4.
Pultrum B, van der Jagt E, van Westreenen H, Van Dullemen H, Kappert P, Groen H . Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study. Cancer Imaging. 2009; 9:19-28. PMC: 2681289. DOI: 10.1102/1470-7330.2009.0004. View

5.
Imanishi S, Shuto K, Aoyagi T, Kono T, Saito H, Matsubara H . Diffusion-weighted magnetic resonance imaging for predicting and detecting the early response to chemoradiotherapy of advanced esophageal squamous cell carcinoma. Dig Surg. 2013; 30(3):240-8. DOI: 10.1159/000351435. View